Tag Archive: ALK

Mar 22 2019

In the News: Mitochondrial Gene Variance, Killing Cancer Cells, NICU Stress Effects, Visually Impaired Driver Safety

In this week’s news roundup, there’s a lot to be proud of as our researchers make impactful discoveries, such as new-found variability in a mitochondrial disease-causing gene and encouraging findings about an antibody-drug conjugate that targets a surface protein expressed in childhood neuroblastomas, effectively killing cancer cells. Wanjiku Njoroge, MD, and colleagues followed mothers of very preterm infants to determine stress in the NICU and its effects five years later, and Allison Curry, PhD, MPH, is changing perceptions about visually impaired drivers.

Read the rest of this entry >>

Jun 3 2013

CBS Sunday Morning Features ALK Cancer Trial at Children’s Hospital

Yesterday, CBS Sunday Morning featured a story on the anaplastic lymphoma kinase, or ALK, clinical trial for lymphoma and neuroblastoma and CHOP’s partnership with the Alex's Lemonade Stand Foundation, which supported the basic research.

Read the rest of this entry >>